PRELUDE THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$3.88
-5.37%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+2.4%
3 months
-11.6%
6 months
-17.4%
1 year
+147.1%
Year to date
+33.8%
52-week range
$1.19 – $6.63
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$309.6M
P/E
-5.1
P/B
2.3
P/S
13.8
Revenue
$22.42M
Net income
-$60.49M
Diluted EPS
-0.73
Gross margin
100.00%
Net margin
-269.70%
Return on equity
-75.40%
Total debt
$17.65M
Cash
$29.73M
Free cash flow
-$33.26M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $5.7M | -$13.92M | 100.00% | -244.10% | -$15.57M |
| Mar 31, 2026 | $4.58M | -$10.39M | 100.00% | -226.70% | -$21.69M |
| Dec 31, 2025 | $5.64M | -$16.46M | 100.00% | -291.80% | $23.12M |
| Sep 30, 2025 | $6.5M | -$19.73M | 100.00% | -303.50% | -$19.12M |
| Jun 30, 2025 | $0 | -$31.23M | — | — | -$26.1M |
| Mar 31, 2025 | $0 | -$32.09M | — | — | -$34.28M |
| Dec 31, 2024 | $0 | -$28.73M | — | — | -$20.8M |
| Sep 30, 2024 | $0 | -$32.27M | — | — | -$27.36M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent PRLD news
All market newsNo ticker-linked stories are in the current archive.